gimli
ABBOTINDIA stock analysis context
ABBOTT INDIA Stock Context for AI Screening
ABBOTT INDIA LIMITED is a large-cap stock in Healthcare. This page summarizes key screening signals for ABBOTT INDIA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ABBOTINDIAPrice
₹27,830.00
1M return
+9.48%
3M return
+5.84%
Market cap
₹59,136.81 cr
PE
38.10
ROE
+39.13%
RSI
63.42
Turnover
₹24.53 cr
Why it can matter in screens
- Momentum: ABBOTINDIA is above 50DMA; RSI is 63.42.
- Returns: 1M +9.48%, 3M +5.84%, 6M -5.90%.
- Liquidity: latest turnover is ₹24.53 cr.
- Valuation: PE 38.10, PB 12.39, ROE +39.13%, ROCE +51.25%.
- Growth: 3Y sales CAGR +9.27%, 3Y profit CAGR +20.98%.
Try these prompts
- Analyze ABBOTT INDIA with valuation, momentum and industry peers
- Compare ABBOTINDIA with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare ABBOTINDIA with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.